Protherics raises
December 19, 2006Research and Development
UK-based biotech company Protherics has raised £38 million, which will be split in a three-pronged move to expand its development …
GSK’s mock vaccine gets EU positive opinion
December 19, 2006Research and Development
GlaxoSmithKline Biological's mock pandemic flu vaccine has received a positive opinion from EU regulators.Daronix is intended to protect against flu …
Are patients about to take charge?
December 18, 2006Medical Communications, Sales and Marketing NHS, healthcare, information, patients
While debate rages about many aspects of the pharmaceutical industry, one thing is agreed: our world is becoming ever-more patient-centred. …
Confidence in UK medicine safety high
December 15, 2006After heavy criticism of UK medicines regulator the MHRA last year, a new survey found there is widespread confidence in …
Tycerb in landmark cancer trial
December 15, 2006Sales and Marketing
GlaxoSmithKline's Tycerb has entered a landmark global trial in the treatment of aggressive breast cancer.This will be the first phase …
Merck outlines turnaround strategy
December 15, 2006Sales and Marketing
Merck's battle to regain profitability and bring new life to its product pipeline is gathering momentum as its unprecedented reorganisation …
Birmingham hospital merger to be first of many
December 15, 2006Debt-ridden Good Hope hospital trust is set to merge with one of the country's best hospitals, the neighbouring Heart of …
Government unveils plans for improved patient involvement
December 14, 2006The views of patients in local healthcare decision making is to be further enhanced by the creation of Local Involvement …
Chance missed to reform NHS finance controls, say managers
December 11, 2006A controversial NHS accounting system, in which in-debt trusts are penalised with budget cuts, will continue, despite protests from health …
National cancer network underpins prostate vaccine trial
December 11, 2006Research and Development
The UK's National Cancer Research Network has given its backing to a phase IIb trial of a promising vaccine for …
GSK buys antibody firm Domantis for
December 11, 2006Research and Development
GlaxoSmithKline has bought Cambridge-based antibody firm Domantis for £230 million.Domantis, a leader in developing the next generation of antibody therapies, …
Is optimisation the new sales mantra?
December 11, 2006Sales and Marketing NHS, sales, strategy
The pharmaceutical industry still refuses to fall out of love with large sales forces, but there are signs beginning to …
TroVax a step nearer to orphan status
December 8, 2006Research and Development
Oxford BioMedica's leading cancer immunotherapy vaccine has received a positive opinion as an orphan drug for renal cancer from the …
Closer scrutiny for high-risk clinical trials
December 8, 2006Research and Development
Wide-ranging changes will be made to the way clinical trials are conducted in the UK following the final report by …
New UK body to fast-track breakthrough research
December 8, 2006Research and Development
Faster approval of NHS clinical trials and NICE recommendations are almost certain following a fundamental shake-up in the way UK …
Novartis readies Prexige for European launch
December 8, 2006Research and Development, Sales and Marketing
Novartis will launch Prexige in its first European markets outside the UK next year following its EMEA approval for osteoarthritic …
UK uptake of new medicines ‘about right’ say doctors
December 7, 2006Sales and Marketing
Most UK doctors think the uptake of new medicines in the country is 'about right' according to a new survey …
Get the best from your R&D team
December 6, 2006Business Services, Research and Development R&D, recruitment
One of the key drivers of much of the recent merger and acquisition activity within the pharmaceutical industry is the …
New treatment for patients resistant to cancer drug Glivec
December 6, 2006Sales and Marketing
The first effective option for chronic myeloid leukaemia (CML) patients resistant or intolerant to prior treatment with Glivec has been …
Smoking cessation drug launched
December 5, 2006Sales and Marketing
Champix, Pfizer's potential blockbuster smoking cessation drug, has been launched in the UK.This first-in-class treatment is designed to activate the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
